Caris Life Sciences (CAI) Invested Capital (2024 - 2026)

Caris Life Sciences' Invested Capital history runs 3 years deep, the most recent figure standing at $173000.0 for Q1 2026.

• In Q1 2026, Invested Capital changed N/A year-over-year to $173000.0; the TTM figure through Mar 2026 stood at $601000.0 (down 99.0% YoY), while the FY2025 annual figure was $169000.0, down 99.72% from the prior year.
• Invested Capital for Q1 2026 stood at $173000.0, up from $169000.0 in the prior quarter.
• The five-year high for Invested Capital was $60.1 million in Q4 2024, with the low at $95000.0 in Q2 2025.
• The 3-year median for Invested Capital is $169000.0 (2025), against an average of $12.1 million.
• Peak annual rise in Invested Capital reached 99.72% in 2025, while the deepest fall reached 99.72% in 2025.
• Caris Life Sciences' Invested Capital stood at $60.1 million in 2024, then plunged by 99.72% to $169000.0 in 2025, then increased by 2.37% to $173000.0 in 2026.
• Business Quant data shows CAI's Invested Capital at $173000.0 in Q1 2026, $169000.0 in Q4 2025, and $164000.0 in Q3 2025.